The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
Abstract
OBJECTIVE: Diabetes mellitus (DM) increases the risk of infections, but the effect of better control has not been thoroughly investigated. RESEARCH DESIGN AND METHODS: With the use of English primary care data, average glycated hemoglobin (HbA1c) during 2008–2009 was estimated for 85,312 patients with DM ages 40–89 years. Infection rates during 2010–2015 compiled from primary care, linked hospital, and mortality records were estimated across 18 infection categories and further summarized as any requiring a prescription or hospitalization or as cause of death. Poisson regression was used to estimate adjusted incidence rate ratios (IRRs) by HbA1c categories across all DM, and type 1 and type 2 DM separately. IRRs also were compared with 153,341 age-sex-practice–matched controls without DM. Attributable fractions (AF%) among patients with DM were estimated for an optimal control scenario (HbA1c 6–7% [42–53 mmol/mol]). RESULTS: Long-term infection risk rose with increasing HbA1c for most outcomes. Compared with patients without DM, those with DM and optimal control (HbA1c 6–7% [42–53 mmol/mol], IRR 1.41 [95% CI 1.36–1.47]) and poor control (≥11% [97 mmol/mol], 4.70 [4.24–5.21]) had elevated hospitalization risks for infection. In patients with type 1 DM and poor control, this risk was even greater (IRR 8.47 [5.86–12.24]). Comparisons within patients with DM confirmed the risk of hospitalization with poor control (2.70 [2.43–3.00]) after adjustment for duration and other confounders. AF% of poor control were high for serious infections, particularly bone and joint (46%), endocarditis (26%), tuberculosis (24%), sepsis (21%), infection-related hospitalization (17%), and mortality (16%). CONCLUSIONS: Poor glycemic control is powerfully associated with serious infections and should be a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Infections in patients with diabetes mellitus: A review of pathogenesis
Alves, C., Casqueiro, J., & Casqueiro, J. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.94253 · Cited by 1,147
Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus
Muller, L. M. A. J., Gorter, K. J., Hak, E., Goudzwaard, W. L., Schellevis, F. G., Hoepelman, A. I. M., & Rutten, G. E. H. M. (2005) · Clinical Infectious Diseases · doi:10.1086/431587 · Cited by 1,023
Stress hyperglycemia: an essential survival response!
Marik, P. E., & Bellomo, R. (2013) · Critical Care · doi:10.1186/cc12514 · Cited by 729
Fedak, K. M., Bernal, A., Capshaw, Z. A., & Gross, S. (2015) · Emerging Themes in Epidemiology · doi:10.1186/s12982-015-0037-4 · Cited by 680
Clinical Inertia in People With Type 2 Diabetes
Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0331 · Cited by 613
Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc17-2131 · Cited by 604
Self-citationCommon infections in diabetes: Pathogenesis, management and relationship to glycaemic control
Peleg, A. Y., Weerarathna, T., McCarthy, J. S., & Davis, T. M. E. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.682 · Cited by 584
Hemmingsen, B., Lund, S. S., Gluud, C., Vaag, A., Almdal, T., Hemmingsen, C., & Wetterslev, J. (2011) · BMJ · doi:10.1136/bmj.d6898 · Cited by 386
An Overview of Methods for Calculating the Burden of Disease Due to Specific Risk Factors
Steenland, K., & Armstrong, B. (2006) · Epidemiology · doi:10.1097/01.ede.0000229155.05644.43 · Cited by 367
Stegenga, M. E., van der Crabben, S. N., Blümer, R. M. E., Levi, M., Meijers, J. C. M., Serlie, M. J., Tanck, M. W. T., Sauerwein, H. P., & van der Poll, T. (2008) · Blood · doi:10.1182/blood-2007-11-121723 · Cited by 341
Diabetes and infection: assessing the association with glycaemic control in population-based studies
Pearson-Stuttard, J., Blundell, S., Harris, T., Cook, D. G., & Critchley, J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00379-4 · Cited by 308
Self-citationImplementation of Treatment Protocols in the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial Research Group (1995) · Diabetes Care · doi:10.2337/diacare.18.3.361 · Cited by 283
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus
Reach, G., Pechtner, V., Gentilella, R., Corcos, A., & Ceriello, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.06.003 · Cited by 251
Mishra, S. C., Chhatbar, K. C., Kashikar, A., & Mehndiratta, A. (2017) · BMJ · doi:10.1136/bmj.j5064 · Cited by 210
Vijan, S., Sussman, J. B., Yudkin, J. S., & Hayward, R. A. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2894 · Cited by 185
The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?
van Crevel, R., van de Vijver, S., & Moore, D. A. J. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30081-x · Cited by 158
Stress Hyperglycemia: An Essential Survival Response!
Marik, P. E., & Bellomo, R. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318283d124 · Cited by 145
Boillat‐Blanco, N., Ramaiya, K. L., Mganga, M., Minja, L. T., Bovet, P., Schindler, C., von Eckardstein, A., Gagneux, S., Daubenberger, C., Reither, K., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv568 · Cited by 125
Stegenga, M. E., van der Crabben, S. N., Dessing, M. C., Pater, J. M., van den Pangaart, P. S., de Vos, A. F., Tanck, M. W. T., Roos, D., Sauerwein, H. P., & van der Poll, T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02348.x · Cited by 117
Hine, J. L., de Lusignan, S., Burleigh, D., Pathirannehelage, S., McGovern, A., Gatenby, P., Jones, S., Jiang, D., Williams, J., Elliot, A. J., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13205 · Cited by 101
Mor, A., Dekkers, O. M., Nielsen, J. S., Beck‐Nielsen, H., Sørensen, H. T., & Thomsen, R. W. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx049 · Cited by 83
Infections in patients with type 2 diabetes in general practice
Bartelink, M.-L. E. L., van der Hoek, L., Freriks, J. P., & Rutten, G. E. H. M. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00023-0 · Cited by 62
Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus
Hair, P. S., Echague, C. G., Rohn, R. D., Krishna, N. K., Nyalwidhe, J. O., & Cunnion, K. M. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-35 · Cited by 60
Czaja, C. A., Rutledge, B. N., Cleary, P. A., Chan, K., Stapleton, A. E., & Stamm, W. E. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.11.021 · Cited by 36
Holden, S. E., Jenkins‐Jones, S., Morgan, C. L., Peters, J. R., Schernthaner, G., & Currie, C. J. (2017) · Diabetic Medicine · doi:10.1111/dme.13332 · Cited by 23
Cited by
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Holman, N., Knighton, P., Kar, P., O'Keefe, J., Curley, M., Weaver, A., Barron, E., Bakhai, C., Khunti, K., Wareham, N. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30271-0 · Cited by 908
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N., Singla, V., Khare, S., & Srivastava, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.044 · Cited by 776
Roncon, L., Zuin, M., Rigatelli, G., & Zuliani, G. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104354 · Cited by 439
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 421
Metadata
- Authors
- Critchley, J. A., Carey, I. M., Harris, T., DeWilde, S., Hosking, F. J., & Cook, D. G.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-08-13
- Volume
- 41
- Issue
- 10
- Pages
- 2127-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2886428084
- Cited by
- 391
- References
- 30
- FWCI
- 30.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.